SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Niko Hensel, Sebastian Rademacher, Peter Claus, Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders, Frontiers in Neuroscience, 2015, 9,

    CrossRef

  2. 2
    Terhi Peuralinna, Liisa Myllykangas, Minna Oinas, Mike A. Nalls, Hannah A. D. Keage, Veli-Matti Isoviita, Miko Valori, Tuomo Polvikoski, Anders Paetau, Raimo Sulkava, Paul G. Ince, Julia Zaccai, Carol Brayne, Bryan J. Traynor, John Hardy, Andrew B. Singleton, Pentti J. Tienari, Genome-wide association study of neocortical Lewy-related pathology, Annals of Clinical and Translational Neurology, 2015, 2, 8
  3. 3
    Dominik Brück, Gregor K. Wenning, Nadia Stefanova, Lisa Fellner, Glia and alpha-synuclein in neurodegeneration: A complex interaction, Neurobiology of Disease, 2015,

    CrossRef

  4. 4
    José Leite, Roberta Hespanhol, Carlos Alberto Buchpiguel, Molecular Imaging in Genetics, Neuroimaging Clinics of North America, 2015, 25, 1, 17

    CrossRef

  5. 5
    Yaping Chu, Jeffrey H. Kordower, The Prion Hypothesis of Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2015, 15, 5

    CrossRef

  6. 6
    Andreas Puschmann, Zbigniew K. Wszolek, Movement Disorders, 2015,

    CrossRef

  7. You have free access to this content7
    Una-Marie Sheerin, Henry Houlden, Nicholas W. Wood, Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician, Movement Disorders Clinical Practice, 2014, 1, 1
  8. 8
    Hao Deng, Lamei Yuan, Genetic variants and animal models in SNCA and Parkinson disease, Ageing Research Reviews, 2014, 15, 161

    CrossRef

  9. 9
    Omid Tavassoly, Joe Kakish, Sergiy Nokhrin, Oleg Dmitriev, Jeremy S. Lee, The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease, European Journal of Medicinal Chemistry, 2014, 88, 42

    CrossRef

  10. 10
    Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy, Biomarkers in Toxicology, 2014,

    CrossRef

  11. 11
    Kaori Itokawa, Takeshi Sekine, Manabu Funayama, Hiroyuki Tomiyama, Miki Fukui, Toshimasa Yamamoto, Naotoshi Tamura, Hiroshi Matsuda, Nobutaka Hattori, Nobuo Araki, A case of α-synuclein gene duplication presenting with head-shaking movements, Movement Disorders, 2013, 28, 3
  12. 12
    Peizhou Jiang, Ming Gan, Abdul Shukkur Ebrahim, Monica Castanedes-Casey, Dennis W. Dickson, Shu-Hui C. Yen, Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites, Neurobiology of Aging, 2013, 34, 5, 1504

    CrossRef

  13. 13
    Han-Joon Kim, Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective, Experimental Neurobiology, 2013, 22, 2, 77

    CrossRef

  14. 14
    Antonio E. Elia, Simona Petrucci, Alfonso Fasano, Marco Guidi, Stefano Valbonesi, Laura Bernardini, Federica Consoli, Alessandro Ferraris, Alberto Albanese, Enza Maria Valente, Alpha-synuclein gene duplication: Marked intrafamilial variability in two novel pedigrees, Movement Disorders, 2013, 28, 6
  15. 15
    Shin-ichiro Kubo, Taku Hatano, Masashi Takanashi, Nobutaka Hattori, Can parkin be a target for future treatment of Parkinson's disease?, Expert Opinion on Therapeutic Targets, 2013, 17, 10, 1133

    CrossRef

  16. 16
    Liyong Wang, Karen Nuytemans, Guney Bademci, Cherylyn Jauregui, Eden R. Martin, William K. Scott, Jeffery M. Vance, Stephan Zuchner, High-Resolution Survey in Familial Parkinson Disease Genes Reveals Multiple Independent Copy Number Variation Events in PARK2, Human Mutation, 2013, 34, 8
  17. 17
    Anelya Kh. Alieva, Maria I. Shadrina, Elena V. Filatova, Vera V. Ustinova, Ekaterina Yu Fedotova, Alexey V. Karabanov, Sergey N. Illarioshkin, Petr A. Slominsky, Polymorphisms in the SNCA Gene: Association with the Risk of Development of the Sporadic Form of Parkinson’s Disease and the Level of SNCA Gene Expression in Peripheral Blood of Patients from Russia, Neuroscience & Medicine, 2013, 04, 04, 208

    CrossRef

  18. 18
    Dale F. Sharrad, Wei-Ping Gai, Simon J.H. Brookes, Selective coexpression of synaptic proteins, α-synuclein, cysteine string protein-α, synaptophysin, synaptotagmin-1, and synaptobrevin-2 in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig ileum, Journal of Comparative Neurology, 2013, 521, 11
  19. 19
    Dale F. Sharrad, Elsbeth de Vries, Simon J.H. Brookes, Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon, Journal of Comparative Neurology, 2013, 521, 3
  20. 20
    Meike Kasten, Christine Klein, The many faces of alpha-synuclein mutations, Movement Disorders, 2013, 28, 6
  21. 21
    Lisa Fellner, Nadia Stefanova, The Role of Glia in Alpha-Synucleinopathies, Molecular Neurobiology, 2013, 47, 2, 575

    CrossRef

  22. 22
    Toru Yasuda, Yasuto Nakata, Hideki Mochizuki, α-Synuclein and Neuronal Cell Death, Molecular Neurobiology, 2013, 47, 2, 466

    CrossRef

  23. 23
    Aoife P. Kiely, Yasmine T. Asi, Eleanna Kara, Patricia Limousin, Helen Ling, Patrick Lewis, Christos Proukakis, Niall Quinn, Andrew J. Lees, John Hardy, Tamas Revesz, Henry Houlden, Janice L. Holton, α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?, Acta Neuropathologica, 2013, 125, 5, 753

    CrossRef

  24. 24
    Namik Kaya, Dilek Colak, Albandary Albakheet, Mohammad Al-Owain, Nada Abu-Dheim, Banan Al-Younes, Jawaher Al-Zahrani, Nahit M. Mukaddes, Aysin Dervent, Naji Al-Dosari, Ali Al-Odaib, Inci V. Kayaalp, Moeenaladin Al-Sayed, Zuhair Al-Hassnan, Michael J. Nester, Mohammad Al-Dosari, Hesham Al-Dhalaan, Aziza Chedrawi, Hulya Gunoz, Bedri Karakas, Nadia Sakati, Fowzan S. Alkuraya, Generaso G. Gascon, Pinar T. Ozand, A novel X-linked disorder with developmental delay and autistic features, Annals of Neurology, 2012, 71, 4
  25. 25
    Curtis R Coughlin, Gunter H Scharer, Tamim H Shaikh, Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns, Genome Medicine, 2012, 4, 10, 80

    CrossRef

  26. 26
    Bram Meeus, Aline Verstraeten, David Crosiers, Sebastiaan Engelborghs, Marleen Van den Broeck, Maria Mattheijssens, Karin Peeters, Ellen Corsmit, Ellen Elinck, Barbara Pickut, Rik Vandenberghe, Patrick Cras, Peter Paul De Deyn, Christine Van Broeckhoven, Jessie Theuns, DLB and PDD: a role for mutations in dementia and Parkinson disease genes?, Neurobiology of Aging, 2012, 33, 3, 629.e5

    CrossRef

  27. 27
    Donna M. Crabtree, Jianhua Zhang, Genetically engineered mouse models of Parkinson's disease, Brain Research Bulletin, 2012, 88, 1, 13

    CrossRef

  28. 28
    Han-Joon Kim, Beom S. Jeon, Min-Yung Yoon, Sung-Sup Park, Kwang-Woo Lee, Increased Expression of Alpha-Synuclein by SNCA Duplication is Associated with Resistance to Toxic Stimuli, Journal of Molecular Neuroscience, 2012, 47, 2, 249

    CrossRef

  29. 29
    I. Ferrer, I. López-Gonzalez, M. Carmona, E. Dalfó, A. Pujol, A. Martínez, Neurochemistry and the non-motor aspects of PD, Neurobiology of Disease, 2012, 46, 3, 508

    CrossRef

  30. 30
    M. Decressac, B. Mattsson, M. Lundblad, P. Weikop, A. Björklund, Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons, Neurobiology of Disease, 2012, 45, 3, 939

    CrossRef

  31. 31
    Angelo Antonini, Manuela Pilleri, Angelo Padoan, Andrea Landi, Salvatore Ferla, Roberta Biundo, Domenico D’Avella, Successful subthalamic stimulation in genetic Parkinson’s disease caused by duplication of the α-synuclein gene, Journal of Neurology, 2012, 259, 1, 165

    CrossRef

  32. 32
    Markos Poulopoulos, Oren A. Levy, Roy N. Alcalay, The neuropathology of genetic Parkinson's disease, Movement Disorders, 2012, 27, 7
  33. 33
    Maya Ando, Manabu Funayama, Yuanzhe Li, Kenichi Kashihara, Yoshitake Murakami, Nobutaka Ishizu, Chizuko Toyoda, Katsuhiko Noguchi, Takashi Hashimoto, Naoki Nakano, Ryogen Sasaki, Yasumasa Kokubo, Shigeki Kuzuhara, Kotaro Ogaki, Chikara Yamashita, Hiroyo Yoshino, Taku Hatano, Hiroyuki Tomiyama, Nobutaka Hattori, VPS35 mutation in Japanese patients with typical Parkinson's disease, Movement Disorders, 2012, 27, 11
  34. 34
    Lena F. Burbulla, Rejko Krüger, Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease, Journal of the Neurological Sciences, 2011, 306, 1-2, 1

    CrossRef

  35. 35
    Karin Wirdefeldt, Hans-Olov Adami, Philip Cole, Dimitrios Trichopoulos, Jack Mandel, Epidemiology and etiology of Parkinson’s disease: a review of the evidence, European Journal of Epidemiology, 2011, 26, S1, 1

    CrossRef

  36. 36
    Kenjiro Ono, Tokuhei Ikeda, Jun-ichi Takasaki, Masahito Yamada, Familial Parkinson disease mutations influence α-synuclein assembly, Neurobiology of Disease, 2011, 43, 3, 715

    CrossRef

  37. 37
    Shigeto Sato, Nobutaka Hattori, Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  38. 38
    Owen A. Ross, Karen N. Conneely, Tao Wang, Carles Vilarino-Guell, Alexandra I. Soto-Ortolaza, Alex Rajput, Zbigniew K. Wszolek, Ryan J. Uitti, Elan D. Louis, Lorraine N. Clark, Matthew J. Farrer, Claudia M. Testa, Genetic variants of α-synuclein are not associated with essential tremor, Movement Disorders, 2011, 26, 14
  39. 39
    Lisa Fellner, Kurt A. Jellinger, Gregor K. Wenning, Nadia Stefanova, Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts, Acta Neuropathologica, 2011, 121, 6, 675

    CrossRef

  40. 40
    Isidro Ferrer, Neuropathology and Neurochemistry of Nonmotor Symptoms in Parkinson's Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  41. 41
    Xabier Elcoroaristizabal Martín, Fernando Gómez Busto, M.C. González Fernández, y Marian M. de Pancorbo, Papel de la genética en la etiología de las sinucleinopatías, Revista Española de Geriatría y Gerontología, 2011, 46, 3

    CrossRef

  42. 42
    David Crosiers, Jessie Theuns, Patrick Cras, Christine Van Broeckhoven, Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes, Journal of Chemical Neuroanatomy, 2011, 42, 2, 131

    CrossRef

  43. 43
    Michael J. Devine, Katrina Gwinn, Andrew Singleton, John Hardy, Parkinson's disease and α-synuclein expression, Movement Disorders, 2011, 26, 12
  44. 44
    S. N. Pchelina, A. K. Emelyanov, A. F. Yakimovskii, D. W. Miller, I. G. Shabalina, A. S. Drozdova, A. L. Schwarzman, Reduced Content of α-Synuclein in Peripheral Blood Leukocytes of Patients with LRRK2-Associated Parkinson’s Disease, Bulletin of Experimental Biology and Medicine, 2011, 150, 6, 679

    CrossRef

  45. 45
    Tiffany Kaul, Joel Credle, Thomas Haggerty, Adam W Oaks, Eliezer Masliah, Anita Sidhu, Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease, BMC Neuroscience, 2011, 12, 1, 79

    CrossRef

  46. 46
    Jack T. Rogers, Sohan Mikkilineni, Ippolita Cantuti-Castelvetri, Deborah H. Smith, Xudong Huang, Sanghamitra Bandyopadhyay, Catherine M. Cahill, Maria L. Maccecchini, Debomoy K. Lahiri, Nigel H. Greig, The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen, Journal of Neural Transmission, 2011, 118, 3, 493

    CrossRef

  47. 47
    Christine Klein, Rosalind Chuang, Connie Marras, Anthony E. Lang, The curious case of phenocopies in families with genetic Parkinson's disease, Movement Disorders, 2011, 26, 10
  48. 48
    S. Orimo, T. Uchihara, T. Kanazawa, Y. Itoh, K. Wakabayashi, A. Kakita, H. Takahashi, Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease, Neuropathology and Applied Neurobiology, 2011, 37, 7
  49. 49
    Violeta Ruipérez, Frédéric Darios, Bazbek Davletov, Alpha-synuclein, lipids and Parkinson’s disease, Progress in Lipid Research, 2010, 49, 4, 420

    CrossRef

  50. 50
    Rivka Inzelberg, Anna Polyniki, Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?, Journal of the Neurological Sciences, 2010, 289, 1-2, 23

    CrossRef

  51. 51
    S. Lesage, A. Brice, Bases moléculaires de la maladie de Parkinson, EMC - Neurologie, 2010, 7, 1, 1

    CrossRef

  52. 52
    S. Lesage, A. Brice, Basi molecolari del morbo di Parkinson, EMC - Neurologia, 2010, 10, 2, 1

    CrossRef

  53. 53
    Takeshi Sekine, Hajime Kagaya, Manabu Funayama, Yuanzhe Li, Hiroyo Yoshino, Hiroyuki Tomiyama, Nobutaka Hattori, Clinical course of the first Asian family with Parkinsonism related to SNCA triplication, Movement Disorders, 2010, 25, 16
  54. 54
    Momo Tani, Hideki Hayakawa, Toru Yasuda, Tomoko Nihira, Nobutaka Hattori, Yoshikuni Mizuno, Hideki Mochizuki, Ectopic expression of α-synuclein affects the migration of neural stem cells in mouse subventricular zone, Journal of Neurochemistry, 2010, 115, 4
  55. 55
    Li Rebekah Feng, Kathleen A. Maguire-Zeiss, Gene Therapy in Parkinsonʼs Disease, CNS Drugs, 2010, 24, 3, 177

    CrossRef

  56. 56
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  57. 57
    Matthew P. Yeager, Randolph A. Coleman, In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease, Journal of Neuroscience Methods, 2010, 188, 1, 151

    CrossRef

  58. 58
    Lin Li, Manabu Funayama, Hiroyuki Tomiyama, Yuanzhe Li, Hiroyo Yoshino, Ryogen Sasaki, Yasumasa Kokubo, Shigeki Kuzuhara, Yoshikuni Mizuno, Nobutaka Hattori, No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients, Neuroscience Letters, 2010, 479, 3, 245

    CrossRef

  59. 59
    Marie Westerlund, Barry Hoffer, Lars Olson, Parkinson's disease: Exit toxins, enter genetics, Progress in Neurobiology, 2010, 90, 2, 146

    CrossRef

  60. 60
    Manabu Funayama, Hiroyuki Tomiyama, Ruey-Meei Wu, Kotaro Ogaki, Hiroyo Yoshino, Yoshikuni Mizuno, Nobutaka Hattori, Rapid screening of ATP13A2 variant with high-resolution melting analysis, Movement Disorders, 2010, 25, 14
  61. 61
    Toru Yasuda, Hideki Mochizuki, The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease, Apoptosis, 2010, 15, 11, 1312

    CrossRef

  62. 62
    Chae Won Shin, Hee Jin Kim, Sung Sup Park, Sung Yeun Kim, Ji Yeon Kim, Beom Seok Jeon, Two Parkinson's disease patients with α-synuclein gene duplication and rapid cognitive decline, Movement Disorders, 2010, 25, 7
  63. 63
    Francesca Sironi, Luca Trotta, Angelo Antonini, Michela Zini, Roberto Ciccone, Erika Della Mina, Nicoletta Meucci, Giorgio Sacilotto, Paola Primignani, Tiziana Brambilla, Domenico A. Coviello, Gianni Pezzoli, Stefano Goldwurm, α-Synuclein multiplication analysis in Italian familial Parkinson disease, Parkinsonism & Related Disorders, 2010, 16, 3, 228

    CrossRef

  64. 64
    Christine Klein, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  65. 65
    M.I. Shadrina, P.A. Slominsky, S.A. Limborska, 2010,

    CrossRef

  66. 66
    Sotiria Sotiriou, Gretchen Gibney, Andreas D. Baxevanis, Robert L. Nussbaum, A single nucleotide polymorphism in the 3′UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease, Neuroscience Letters, 2009, 461, 2, 196

    CrossRef

  67. 67
    Andreas Puschmann, Zbigniew K. Wszolek, Matthew Farrer, Lars Gustafson, Håkan Widner, Christer Nilsson, Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?, Parkinsonism & Related Disorders, 2009, 15, 5, 390

    CrossRef

  68. 68
    Alex Rajput, Carles Vilariño-Güell, Michele L. Rajput, Owen A. Ross, Alexandra I. Soto-Ortolaza, Sarah J. Lincoln, Stephanie A. Cobb, Michael G. Heckman, Matthew J. Farrer, Ali Rajput, Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population, Movement Disorders, 2009, 24, 16
  69. 69
    Yaping Chu, Hemraj Dodiya, Patrick Aebischer, C. Warren Olanow, Jeffrey H. Kordower, Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions, Neurobiology of Disease, 2009, 35, 3, 385

    CrossRef

  70. 70
    E. V. Semenova, M. I. Shadrina, P. A. Slominsky, S. N. Illarioshkin, G. Kh. Bagyeva, A. V. Karabanov, I. A. Ivanova-Smolenskaia, S. A. Limborska, Analysis of the α-synuclein gene dosage variation associated with autosomal dominant form of Parkinson’s disease, Russian Journal of Genetics, 2009, 45, 4, 504

    CrossRef

  71. 71
    Zhi Yao, Nicholas W. Wood, Cell Death Pathways in Parkinson's Disease: Role of Mitochondria, Antioxidants & Redox Signaling, 2009, 11, 9, 2135

    CrossRef

  72. 72
    Marilyn M. Li, Hans C. Andersson, Clinical Application of Microarray-Based Molecular Cytogenetics: An Emerging New Era of Genomic Medicine, The Journal of Pediatrics, 2009, 155, 3, 311

    CrossRef

  73. 73
    Toru Yasuda, Tomoko Nihira, Yong-Ri Ren, Xu-Qing Cao, Keiichiro Wada, Rieko Setsuie, Tomohiro Kabuta, Keiji Wada, Nobutaka Hattori, Yoshikuni Mizuno, Hideki Mochizuki, Effects of UCH-L1 on α-synuclein over-expression mouse model of Parkinson’s disease, Journal of Neurochemistry, 2009, 108, 4
  74. 74
    Kenya Nishioka, Owen A. Ross, Kenji Ishii, Jennifer M. Kachergus, Kiichi Ishiwata, Mayumi Kitagawa, Satoshi Kono, Tomokazu Obi, Koichi Mizoguchi, Yuichi Inoue, Hisamasa Imai, Masashi Takanashi, Yoshikuni Mizuno, Matthew J. Farrer, Nobutaka Hattori, Expanding the clinical phenotype of SNCA duplication carriers, Movement Disorders, 2009, 24, 12
  75. 75
    J.P.M. van der Vegt, B.F.L. van Nuenen, B.R. Bloem, C. Klein, H.R. Siebner, Imaging the impact of genes on Parkinson's disease, Neuroscience, 2009, 164, 1, 191

    CrossRef

  76. 76
    Katrin Beyer, Montserrat Domingo-Sàbat, Aurelio Ariza, Molecular Pathology of Lewy Body Diseases, International Journal of Molecular Sciences, 2009, 10, 3, 724

    CrossRef

  77. 77
    Xiaomin Su, Howard J. Federoff, Kathleen A. Maguire-Zeiss, Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity, Neurotoxicity Research, 2009, 16, 3, 238

    CrossRef

  78. 78
    Masayo Fujita, Akio Sekigawa, Kazunari Sekiyama, Shuei Sugama, Makoto Hashimoto, Neurotoxic conversion of β-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?, Journal of Neurology, 2009, 256, S3, 286

    CrossRef

  79. 79
    J. Eric Ahlskog, Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, 10, 721

    CrossRef

  80. 80
    S. Lesage, A. Brice, Parkinson's disease: from monogenic forms to genetic susceptibility factors, Human Molecular Genetics, 2009, 18, R1, R48

    CrossRef

  81. 81
    Taku Hatano, Shin-ichiro Kubo, Shigeto Sato, Nobutaka Hattori, Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease, Journal of Neurochemistry, 2009, 111, 5
  82. 82
    Karen Nuytemans, Bram Meeus, David Crosiers, Nathalie Brouwers, Dirk Goossens, Sebastiaan Engelborghs, Philippe Pals, Barbara Pickut, Marleen Van den Broeck, Ellen Corsmit, Patrick Cras, Peter P. De Deyn, Jurgen Del-Favero, Christine Van Broeckhoven, Jessie Theuns, Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population, Human Mutation, 2009, 30, 7
  83. 83
    Nobutaka Hattori, Mei Wang, Hikari Taka, Tsutomu Fujimura, Asako Yoritaka, Shin-ichiro Kubo, Hideki Mochizuki, Toxic effects of dopamine metabolism in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S35

    CrossRef

  84. 84
    S. L. Lee, D. G. Murdock, J. L. McCauley, Y. Bradford, A. Crunk, L. McFarland, L. Jiang, T. Wang, N. Schnetz-Boutaud, J. L. Haines, A Genome-wide Scan in an Amish Pedigree with Parkinsonism, Annals of Human Genetics, 2008, 72, 5
  85. 85
    Li-wen Ko, Hwai-hwa C. Ko, Wen-Lang Lin, Jayanranyan G. Kulathingal, Shu-Hui C. Yen, Aggregates Assembled From Overexpression of Wild-Type α-Synuclein are not Toxic to Human Neuronal Cells, Journal of Neuropathology and Experimental Neurology, 2008, 67, 11, 1084

    CrossRef

  86. 86
    Josephine A. Wright, David R. Brown, Alpha-synuclein and its role in metal binding: Relevance to Parkinson's disease, Journal of Neuroscience Research, 2008, 86, 3
  87. 87
    Satoshi Orimo, Toshiki Uchihara, Ayako Nakamura, Fumiaki Mori, Takeshi Ikeuchi, Osamu Onodera, Masatoyo Nishizawa, Atsushi Ishikawa, Akiyoshi Kakita, Koichi Wakabayashi, Hitoshi Takahashi, Cardiac sympathetic denervation in Parkinson’s disease linked to SNCA duplication, Acta Neuropathologica, 2008, 116, 5, 575

    CrossRef

  88. 88
    Satoshi Orimo, Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies, Rinsho Shinkeigaku, 2008, 48, 1, 11

    CrossRef

  89. 89
    Bassem A. Bejjani, Lisa G. Shaffer, Clinical Utility of Contemporary Molecular Cytogenetics, Annual Review of Genomics and Human Genetics, 2008, 9, 1, 71

    CrossRef

  90. 90
    K. Markopoulou, D. W. Dickson, R. D. McComb, Z. K. Wszolek, L. Katechalidou, L. Avery, M. S. Stansbury, B. A. Chase, Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease, Acta Neuropathologica, 2008, 116, 1, 25

    CrossRef

  91. 91
    Brit Mollenhauer, Valerie Cullen, Ilana Kahn, Bryan Krastins, Tiago F. Outeiro, Imelda Pepivani, Juliana Ng, Walter Schulz-Schaeffer, Hans A. Kretzschmar, Pamela J. McLean, Claudia Trenkwalder, David A. Sarracino, Jean-Paul VonSattel, Joseph J. Locascio, Omar M.A. El-Agnaf, Michael G. Schlossmacher, Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration, Experimental Neurology, 2008, 213, 2, 315

    CrossRef

  92. 92
    Esther Dalfó, Isidre Ferrer, Early α-synuclein lipoxidation in neocortex in Lewy body diseases, Neurobiology of Aging, 2008, 29, 3, 408

    CrossRef

  93. 93
    Katja Lohmann, Christine Klein, GENETICS OF PARKINSON DISEASE, CONTINUUM: Lifelong Learning in Neurology, 2008, 14, 90

    CrossRef

  94. 94
    Owen A. Ross, Adam T. Braithwaite, Lisa M. Skipper, Jennifer Kachergus, Mary M. Hulihan, Frank A. Middleton, Kenya Nishioka, Julia Fuchs, Thomas Gasser, Demetrius M. Maraganore, Charles H. Adler, Lydie Larvor, Marie-Christine Chartier-Harlin, Christer Nilsson, J. William Langston, Katrina Gwinn, Nobutaka Hattori, Matthew J. Farrer, Genomic investigation of α-synuclein multiplication and parkinsonism, Annals of Neurology, 2008, 63, 6
  95. 95
    G. Muntané, E. Dalfó, A. Martinez, I. Ferrer, Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies, Neuroscience, 2008, 152, 4, 913

    CrossRef

  96. 96
    Y. Mizuno, N. Hattori, S.-i. Kubo, S. Sato, K. Nishioka, T. Hatano, H. Tomiyama, M. Funayama, Y. Machida, H. Mochizuki, Progress in the pathogenesis and genetics of Parkinson's disease, Philosophical Transactions of the Royal Society B: Biological Sciences, 2008, 363, 1500, 2215

    CrossRef

  97. 97
    Carola Schiesling, Nicole Kieper, Kay Seidel, Rejko Krüger, Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease, Neuropathology and Applied Neurobiology, 2008, 34, 3
  98. 98
    Andis Klegeris, Steven Pelech, Benoit I. Giasson, John Maguire, Hong Zhang, Edith G. McGeer, Patrick L. McGeer, α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia, Neurobiology of Aging, 2008, 29, 5, 739

    CrossRef

  99. 99
    Tshianda N.M. Alerte, Akinwande A. Akinfolarin, Emily E. Friedrich, Samantha A. Mader, Chang-Sook Hong, Ruth G. Perez, α-Synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: Lessons from viral transduction of knockout mice, Neuroscience Letters, 2008, 435, 1, 24

    CrossRef

  100. 100
    Andrei Surguchov, 2008,

    CrossRef

  101. 101
    Mingyao Ying, Valina L. Dawson, Ted M. Dawson, Parkinson's Disease, 2008,

    CrossRef

  102. 102
    Owen A. Ross, Adam T. Braithwaite, Matthew J. Farrer, Parkinson's Disease, 2008,

    CrossRef

  103. 103
    Matthew Farrer, Dementias, 2008,

    CrossRef

  104. 104
    X. William Yang, Xiao-Hong Lu, Parkinson's Disease, 2008,

    CrossRef

  105. 105
    Jennifer A. Lee, Claudia M.B. Carvalho, James R. Lupski, A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders, Cell, 2007, 131, 7, 1235

    CrossRef

  106. 106
    Yaping Chu, Jeffrey H. Kordower, Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?, Neurobiology of Disease, 2007, 25, 1, 134

    CrossRef

  107. 107
    Nobutaka Hattori, Shigeto Sato, Animal models of Parkinson's disease: Similarities and differences between the disease and models, Neuropathology, 2007, 27, 5
  108. 108
    Nathan Pankratz, Tatiana Foroud, Genetics of Parkinson disease, Genetics in Medicine, 2007, 9, 12, 801

    CrossRef

  109. 109
    Christine Klein, Katja Lohmann-Hedrich, Impact of recent genetic findings in Parkinson??s disease, Current Opinion in Neurology, 2007, 20, 4, 453

    CrossRef

  110. 110
    S. Lesage, A. Dürr, A. Brice, LRRK2: a link between familial and sporadic Parkinson’s disease?, Pathologie Biologie, 2007, 55, 2, 107

    CrossRef

  111. 111
    Klaus Beyer, Mechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane, Cell Biochemistry and Biophysics, 2007, 47, 2, 285

    CrossRef

  112. 112
    Oronzo Scarciolla, Francesco Brancati, Enza Maria Valente, Alessandro Ferraris, Maria Vittoria De Angelis, Stefano Valbonesi, Barbara Garavaglia, Antonino Uncini, Giandomenico Palka, Liborio Stuppia, Bruno Dallapiccola, Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements, Movement Disorders, 2007, 22, 15
  113. 113
    Eng-King Tan, Lisa M. Skipper, Pathogenic mutations in Parkinson disease, Human Mutation, 2007, 28, 7
  114. 114
    Katrin Beyer, Aurelio Ariza, Protein Aggregation Mechanisms in Synucleinopathies, Journal of Neuropathology and Experimental Neurology, 2007, 66, 11, 965

    CrossRef

  115. 115
    Shahin Zibaee, Ross Jakes, Graham Fraser, Louise C. Serpell, R. Anthony Crowther, Michel Goedert, Sequence Determinants for Amyloid Fibrillogenesis of Human α-Synuclein, Journal of Molecular Biology, 2007, 374, 2, 454

    CrossRef

  116. 116
    Yoshikuni Mizuno, Nobutaka Hattori, Hideki Mochizuki, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  117. 117
    Matthew James Farrer, Genetics of Parkinson disease: paradigm shifts and future prospects, Nature Reviews Genetics, 2006, 7, 4, 306

    CrossRef

  118. 118
    Jennifer A. Lee, James R. Lupski, Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders, Neuron, 2006, 52, 1, 103

    CrossRef

  119. 119
    A. Wood-Kaczmar, S. Gandhi, N.W. Wood, Understanding the molecular causes of Parkinson's disease, Trends in Molecular Medicine, 2006, 12, 11, 521

    CrossRef

  120. 120
    Katrin Beyer, α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers, Acta Neuropathologica, 2006, 112, 3, 237

    CrossRef